Literature DB >> 36220967

Residual risks of comorbidities after parathyroidectomy in a nationwide cohort of patients with primary hyperparathyroidism.

Sung Hye Kong1,2, Jung Hee Kim2,3, Man Young Park4, Sang Wan Kim5,6, Chan Soo Shin2,3.   

Abstract

PURPOSE: Primary hyperparathyroidism (PHPT) is a common endocrine disorder with increasing incidence, while epidemiologic data in Asian population has been lacking. Therefore, we aimed to identify the incidence, prognosis, and prognostic factors of PHPT patients who underwent parathyroidectomy in Korea.
METHODS: In this retrospective nationwide cohort, patients with PHPT were defined as those with diagnostic codes of PHPT and procedural codes for parathyroidectomy, excluding chronic renal failure or secondary hyperparathyroidism based on National Health Insurance Services database in Korea in 2002-2018. Main primary outcomes were all-cause mortality, cardiovascular, and cerebrovascular events.
RESULTS: A total of 5561 patients were diagnosed with PHPT and had parathyroidectomy. The mean age was 54.5 years, and 71.8% were women. The age-standardized incidence was 10.1/100,000 person-year in 2018, rising from 1.7/100,000 person-year in 2002. During a mean of 5.9 years, history of cardiovascular disease, mood disorder, and genitourinary stone had increased risks of mortality with hazard ratios (HRs) of 1.59 (95% confidence interval [CI] 1.10-2.29), 1.43 (CI 1.14-1.80), and 1.40 (CI 1.09-1.80), respectively. History of hypertension, cerebrovascular disease, diabetes mellitus, and mood disorder were risk factors for cardiovascular events with HRs of 1.42 (CI 1.22-1.66), 1.29 (CI 1.05-1.58), 1.22 (CI 1.07-1.40), and 1.14 (CI 1.00-1.29), respectively. Mood disorder was a significant risk factor for cerebrovascular events (HR 1.30, CI 1.11-1.52).
CONCLUSION: The incidence of PHPT patients who underwent parathyroidectomy has been rising in Korea as reported in other countries. Patients with complications, especially mood disorder, had increased cardiovascular and cerebrovascular events and mortality risks.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cardiovascular disease; Cerebrovascular disease; Mood disorder; Nationwide cohort; Primary hyperparathyroidism

Year:  2022        PMID: 36220967     DOI: 10.1007/s12020-022-03211-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  40 in total

1.  Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.

Authors:  Tsering Dhondup; Wonngarm Kittanamongkolchai; Lisa E Vaughan; Ramila A Mehta; Jasdeep K Chhina; Felicity T Enders; LaTonya J Hickson; John C Lieske; Andrew D Rule
Journal:  Am J Kidney Dis       Date:  2018-08-23       Impact factor: 8.860

2.  Depressive symptoms and mortality risk in a national sample: confounding effects of health status.

Authors:  Susan A Everson-Rose; James S House; Richard P Mero
Journal:  Psychosom Med       Date:  2004 Nov-Dec       Impact factor: 4.312

3.  Mortality after surgery for primary hyperparathyroidism: results from a nationwide cohort.

Authors:  M Nilsson; K Ivarsson; M Thier; E Nordenström; A Bergenfelz; M Almquist
Journal:  Br J Surg       Date:  2021-07-23       Impact factor: 6.939

4.  Cardiovascular events before and after surgery for primary hyperparathyroidism.

Authors:  Peter Vestergaard; Charlotte L Mollerup; Vibe Gedsø Frøkjaer; Peer Christiansen; Mogens Blichert-Toft; Leif Mosekilde
Journal:  World J Surg       Date:  2003-02       Impact factor: 3.352

5.  The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992.

Authors:  R A Wermers; S Khosla; E J Atkinson; S F Hodgson; W M O'Fallon; L J Melton
Journal:  Ann Intern Med       Date:  1997-03-15       Impact factor: 25.391

6.  Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010).

Authors:  Marcio L Griebeler; Ann E Kearns; Euijung Ryu; Matthew A Hathcock; L Joseph Melton; Robert A Wermers
Journal:  Bone       Date:  2014-12-11       Impact factor: 4.398

7.  Clinical evaluation of total serum calcium in primary hyperparathyroidism and the risk of death after surgery.

Authors:  G Hedbäck; A Odén
Journal:  Eur J Clin Invest       Date:  1995-01       Impact factor: 4.686

8.  Postoperative mortality in parathyroid surgery in Sweden during five decades: improved outcome despite older patients.

Authors:  S Norenstedt; A Ekbom; L Brandt; J Zedenius; I-L Nilsson
Journal:  Eur J Endocrinol       Date:  2008-11-28       Impact factor: 6.664

9.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.

Authors:  John P Bilezikian; Maria Luisa Brandi; Richard Eastell; Shonni J Silverberg; Robert Udelsman; Claudio Marcocci; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

10.  Increasing incidence of primary hyperparathyroidism in Denmark.

Authors:  Ali Abood; Peter Vestergaard
Journal:  Dan Med J       Date:  2013-02       Impact factor: 1.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.